Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for colon cancer

R M Zwacka1, M G Dunlop

  • 1University of Edinburgh, Department of Surgery, Western General Hospital, United Kingdom.

Hematology/Oncology Clinics of North America
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thieno[2,3-<i>b</i>]pyridine compounds potently inhibit prostate cancer growth and motility.

Endocrine oncology (Bristol, England)·2025
Same author

Survival outcomes in patients with sigmoid volvulus.

International journal of colorectal disease·2025
Same author

A feasibility study of perioperative vitamin D supplementation in patients undergoing colorectal cancer resection.

Frontiers in nutrition·2023
Same author

Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.

The British journal of surgery·2023
Same author

Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects.

BMC medicine·2021
Same author

Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.

BJS open·2021

Gene therapy offers novel approaches for colorectal cancer, with ongoing US trials focusing on enzyme/prodrug systems, tumor suppressor gene replacement, and immune-gene therapy. These early-stage trials evaluate safety and gene delivery for future colorectal cancer treatments.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Colorectal cancer necessitates novel therapeutic strategies due to high incidence and limited efficacy of current treatments.
  • Gene therapy is an emerging modality with ongoing research and clinical trials for various cancers.

Purpose of the Study:

  • To review five ongoing or pending gene therapy trials for colon carcinoma in the United States.
  • To categorize current gene therapy approaches and discuss their potential and challenges.

Main Methods:

  • Review of five gene therapy clinical trials in the US for colon carcinoma.
  • Categorization of gene therapy approaches into enzyme/prodrug systems, tumor suppressor gene replacement, and immune-gene therapy.
  • Discussion of vector systems, primarily replication-deficient recombinant adenoviral vectors.

Related Experiment Videos

Main Results:

  • Five gene therapy trials are in progress or approval stages, utilizing diverse strategies like HSVtk/ganciclovir, CD/5-fluorocytosine, p53 replacement, and cytokine/antigen expression.
  • Replication-deficient recombinant adenoviral vectors are the predominant delivery system.
  • Phase I trials are primarily assessing safety and gene delivery, with potential insights into therapeutic effects.

Conclusions:

  • Gene therapy for colon cancer is in its early stages, facing challenges in toxicity, tumor specificity, and efficient delivery.
  • Future directions include adjuvant therapy, prophylactic immunization, and combination treatments with conventional therapies.
  • Continued molecular research and improved delivery systems are crucial for advancing colon cancer gene therapy.